"According to the latest report published by Data Bridge Market Research, the Asia-Pacific Molecular Diagnostics Market The Asia-Pacific molecular diagnostics market size was valued at USD 9.47 billion in 2025 and is expected to reach USD 16.02 billion by 2033, at a CAGR of 6.8% during the forecast period Winning Asia-Pacific Molecular Diagnostics...

" According to the latest report published by Data Bridge Market Research, the Molecular Diagnostics Market The global molecular diagnostics market was valued at USD 25.8 billion in 2024 and is expected to reach USD 70.05 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.30%, primarily driven by high...

The global molecular diagnostics market was valued at USD 18.8 billion in 2025. It is projected to reach USD 19.4 billion in 2026 and USD 25.6 billion by 2033, growing at a CAGR of 4.1% from 2026 to 2033, according to Grand View Research. North America led with a 44.1% revenue share in 2025. That growth is steady rather than explosive. Most of the value is concentrated in a few places:...

The global molecular imaging market is experiencing significant growth, driven by advancements in imaging technologies, increased prevalence of chronic diseases, and a growing emphasis on personalized medicine. Molecular imaging, which allows for the visualization of biological processes at the molecular and cellular levels within living organisms, is becoming an indispensable tool in modern...

In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...

The rapid evolution of cancer molecular diagnostics, increasing adoption of molecular diagnostics in oncology, and growing demand for precision oncology diagnostics are transforming cancer detection and treatment worldwide. Molecular diagnostic technologies enable healthcare professionals to identify genetic mutations, biomarkers, and tumor-specific molecular...

"PCR Multiplex Assays Market Summary: According to the latest report published by Data Bridge Market Research, the PCR Multiplex Assays Market  CAGR Value The global PCR multiplex assays market size was valued at USD 632.60 Million in 2025 and is expected to reach USD 990.14 Million by 2033, at a CAGR of 5.76% during the forecast period The supreme...

The Poct Molecular Diagnostics Market continues to expand as clinicians, laboratory directors, and public health officials increasingly embrace rapid nucleic acid amplification testing at or near the patient care site. With POCT molecular diagnostics enabling detection of infectious pathogens, genetic markers, and antimicrobial resistance genes within minutes to hours rather than days, the...

" According to the latest report published by Data Bridge Market Research, the Polymerase Chain Reaction Market CAGR Value The global polymerase chain reaction market size was valued at USD 10.88 billion in 2024 and is expected to reach USD 24.03 billion by 2032, at a CAGR of 10.4% during the forecast period Polymerase Chain Reaction Market is the...

The U.S. Oncology Based Molecular Diagnostics Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. Oncology Based Molecular Diagnostics Market, offers a holistic view of the market. It examines the market’s structure, growth drivers,...

The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...

The HPV testing and Pap test market is expanding as healthcare systems place greater emphasis on cervical cancer prevention, early diagnosis, and accessible screening. The market was valued at USD 3.6 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 6.2 billion by 2033, registering a 7.2% CAGR from 2026 to 2033. Technological advancements in testing products, the...

Microfluidics Market: Transforming Precision Diagnostics, Drug Discovery, and Point-of-Care Healthcare Microfluidics Market Snapshot The Microfluidics Market is witnessing remarkable growth as miniaturized fluid-handling technologies revolutionize healthcare diagnostics, life sciences research, pharmaceutical development, and industrial applications. According to M2Square...

The allergy diagnostics and therapeutics market is expanding as the prevalence of allergic conditions rises and demand grows for earlier diagnosis, advanced testing, and effective treatment options. The market was valued at USD 37.1 billion in 2025 and is projected to reach USD 40.2 billion in 2026 and USD 78.0 billion by 2033, registering a CAGR of 10.0% from 2026 to 2033. Increasing adoption...